Teva Pharmaceutical Industries (TEVA) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free TEVA Stock Alerts $13.04 +0.03 (+0.23%) (As of 12:04 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineThe Sound Shore Fund Q1 2024 Letter To Shareholdersseekingalpha.com - April 24 at 10:36 AMPrivate Management Group Inc. Sells 98,730 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - April 23 at 10:25 PMNumber of Cape pharmacies ditch Israeli medicines to become ‘Apartheid Free Zone’msn.com - April 19 at 7:21 AMAlvotech, Teva signs deal to expand access for Humira biosimilar in U.S.msn.com - April 19 at 7:21 AMTeva Pharmaceutical Industries Limited (NYSE:TEVA) to Post Q2 2025 Earnings of $0.57 Per Share, Zacks Research Forecastsamericanbankingnews.com - April 19 at 3:02 AMZacks Research Analysts Boost Earnings Estimates for Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - April 18 at 6:31 AMMigdal Insurance & Financial Holdings Ltd. Acquires 1,860,000 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - April 17 at 2:37 PMTeva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tabletsfinance.yahoo.com - April 16 at 8:42 AMHarel Insurance Investments & Financial Services Ltd. Has $297.89 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - April 14 at 1:28 PMTeva Pharmaceutical Industries (NYSE:TEVA) Shares Down 5.3% marketbeat.com - April 12 at 2:51 PMMeitav Investment House Ltd. Acquires 1,950,500 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - April 12 at 12:48 AMPfizer unit to settle Effexor XR antitrust claims in $39M dealmsn.com - April 11 at 1:28 PMTeva Confirms Efficacy, Safety Of AJOVY In Prevention Of Migraine - Quick Factsmarkets.businessinsider.com - April 11 at 1:28 PMTeva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in Chinabusinesswire.com - April 11 at 8:30 AMTeva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024businesswire.com - April 9 at 4:30 PMTeva Pharmaceutical Industries Sees Unusually Large Options Volume (NYSE:TEVA)marketbeat.com - April 9 at 2:46 PMTeva Pharmaceutical Industries (NYSE:TEVA) Hits New 1-Year High at $14.47marketbeat.com - April 8 at 1:45 PMNew Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024finance.yahoo.com - April 6 at 1:13 PMNew Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024businesswire.com - April 6 at 1:00 PMTeva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidatefinance.yahoo.com - April 4 at 8:52 AMBiden touts inhaler price drops with Bernie Sanders: "Finally, finally we beat big Pharma"msn.com - April 3 at 5:49 PMTeva, Viatris win new chance to challenge J&J schizophrenia drug patentreuters.com - April 1 at 11:53 AMClinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreementfinance.yahoo.com - April 1 at 8:56 AMAssenagon Asset Management S.A. Has $6.05 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - March 31 at 4:42 AMQ3 2025 EPS Estimates for Teva Pharmaceutical Industries Limited Raised by Zacks Research (NYSE:TEVA)marketbeat.com - March 31 at 1:48 AMShort Interest in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Drops By 28.9%marketbeat.com - March 29 at 8:18 PMBrokers Set Expectations for Teva Pharmaceutical Industries Limited's Q3 2025 Earnings (NYSE:TEVA)marketbeat.com - March 29 at 8:53 AMExperts say Medicaid rebate change is behind inhaler price cutsmsn.com - March 28 at 4:06 PMTeva stock trades in the green for seventh straight sessionseekingalpha.com - March 28 at 12:06 AMSpotlight on Teva Pharmaceutical Indus: Analyzing the Surge in Options Activitybenzinga.com - March 27 at 7:06 PMTeva Pharmaceutical Industries Limited: HOLD on weak near-term earnings outlookfinance.yahoo.com - March 27 at 2:06 PMWellington Management Group LLP Purchases 102,261 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - March 27 at 4:17 AMInstitutional investors have a lot riding on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with 67% ownershipfinance.yahoo.com - March 26 at 9:41 AMTeva Pharmaceutical Industries: Potential Outweighs Concernsseekingalpha.com - March 25 at 6:40 PM25 Countries with the Lowest Fertility Ratesfinance.yahoo.com - March 24 at 9:50 PMTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Purchased by SG Americas Securities LLCmarketbeat.com - March 24 at 11:16 AMTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Bought by AustralianSuper Pty Ltdmarketbeat.com - March 23 at 5:34 PMTeva Pharmaceutical Industries (NYSE:TEVA) Sets New 12-Month High at $13.93marketbeat.com - March 22 at 3:38 PMDeutsche Bank AG Has $23.48 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - March 19 at 4:41 AMTeva Pharmaceutical Industries Limited (NYSE:TEVA) EVP Sells $1,352,000.00 in Stockinsidertrades.com - March 17 at 6:58 AMInvestors Buy High Volume of Call Options on Teva Pharmaceutical Industries (NYSE:TEVA)marketbeat.com - March 14 at 3:35 PMTEVA Mar 2024 20.000 callfinance.yahoo.com - March 14 at 2:11 PMTeva Pharma Industries Ltd ADR (TEVAy)uk.investing.com - March 14 at 9:10 AMTudor Investment Corp Et Al Buys 208,776 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - March 9 at 10:36 AMTeva Pharmaceutical Industries (NYSE:TEVA) Upgraded to "Neutral" at JPMorgan Chase & Co.marketbeat.com - March 8 at 8:38 AMTEVA Mar 2024 12.000 putsg.finance.yahoo.com - March 7 at 10:21 PMTEVA Mar 2024 13.000 callsg.finance.yahoo.com - March 7 at 10:21 PMTEVA Mar 2024 17.000 callca.finance.yahoo.com - March 6 at 9:03 PMTEVA Apr 2024 15.500 callca.finance.yahoo.com - March 6 at 9:03 PMTejara Capital Ltd Increases Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)marketbeat.com - March 6 at 5:40 PM Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address “The Biggest Bubble of All Time” – Here’s What to Do. (Ad)Despite AI's incredible run-up in 2023, we're getting some conflicting messages. Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse. Even AI leaders (the people who benefit the most!) are getting worried. Just click here. TEVA Media Mentions By Week TEVA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.880.44▲Average Medical News Sentiment TEVA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼76▲TEVA Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VTRS News BGNE News KRTX News BMRN News RDY News SRPT News UTHR News ALNY News CTLT News GMAB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
